Food interaction and steady-state pharmacokinetics of itraconazole oral solution in healthy volunteers

Pharmacotherapy

Volumn 18, Issue 2 I, 1998, Pages 295-301

  Barone, Joseph A ^a   Moskovitz, Bruce L ^a   Guarnieri, Joseph ^a   Hassell, Alan E ^a   Colaizzi, John L ^a   Bierman, Robert H ^a   Jessen, Lois ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ITRACONAZOLE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIARRHEA; DIET RESTRICTION; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG HALF LIFE; ERYTHEMA MULTIFORME; FOOD DRUG INTERACTION; HEADACHE; HUMAN; HUMAN EXPERIMENT; MALE; MYCOSIS; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; RASH; SOMNOLENCE;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTIFUNGAL AGENTS; BETA-CYCLODEXTRINS; BIOLOGICAL AVAILABILITY; CROSS-OVER STUDIES; CYCLODEXTRINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION; EATING; FASTING; FOOD; FOOD-DRUG INTERACTIONS; HUMANS; ITRACONAZOLE; MALE; MIDDLE AGED; PHARMACEUTICAL SOLUTIONS;

EID: 0031919504     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Janssen Pharmaceutica Inc. Sporanox (itraconazole) capsules package insert. Titusville, NJ; 1995.
2. Cleary JD, Taylor JW, Chapman SW. Itraconazole in antifungal therapy. Ann Pharmacother 1992;26:502-9.
3. Hay RJ, Dupont B, Graybill JR. First international symposium on itraconazole: a summary. Rev Infect Dis 1987;9(suppl 1):S1-3.
4. Barchiesi F, Colombo AL, McGough DA, Fothergill AW, Rinaldi MG. In vitro activity of itraconazole against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus. Antimicrob Agents Chemother 1994;38:1530-3.
5. Blatchford NR. Treatment of oral candidiasis with itraconazole: a review. J Am Acad Dermatol 1990;23:565-7.
6. White A, Goetz MB. Azole-resistant Candida albicans: report of two cases of resistance to fluconazole and review. Clin Infect Dis 1994;19:687-92.
7. Barone JA, Koh JG, Bierman RH, et al. Food interaction and steady-state pharmacokinetics of itraconazole capsules in healthy male volunteers. Antimicrob Agents Chemother 1993;37:778-84.
8. Hardin TC, Graybill JR, Fetchick R, Woestenborghs R, Rinaldi MG, Kuhn JG. Pharmacokinetics of itraconazole following oral administration to normal volunteers. Antimicrob Agents Chemother 1988;32:1310-13.
9. Janssen Pharmaceutica Inc. Sporanox (itraconazole) oral solution package insert. Titusville, NJ; 1997.
10. Van de Velde VJS, Van Peer AP, Heykants JJP, et al. Effect of food on the pharmacokinetics of a new hydroxypropyl-β-cyclodextrin formulation of itraconazole. Pharmacotherapy 1996;16:424-8.
11. Denning DW, Lee JY, Hostetler JS, et al. NIAID Mycoses Study Group multicenter trial of oral itraconazole therapy for invasive aspergillosis. Am J Med 1994;97:135-44.
12. Cartledge JD, Midgely J, Gazzard BG. Itraconazole solution: higher serum drug concentrations and better clinical response rates than the capsule formulation in acquired immunodeficiency syndrome patients with candidosis. J Clin Pathol 1997;50:477-80.
13. Woestenborghs R, Lorreyne W, Heykants J. Determination of itraconazole in plasma and animal tissues by high performance liquid chromatography. J Chromatogr 1987;413:332-7.
14. Metzler C. Sample sizes for bioequivalence studies. Stat Med 1991;10:961-70.
15. Van Peer A, Woestenborghs R, Heykants J, Gasparini R, Roelant D, Cauwenbergh G. The effects of food and dose on the oral systemic availability of itraconazole in healthy subjects. Eur J Clin Pharmacol 1989;36:423-6.
16. Graybill JR, Vazquez J, Darouiche RO, et al. Itraconazole oral solution: a novel and effective treatment for oropharyngeal candidiasis in HIV/AIDS patients. Am J Med In press.
17. Murray PA, Koletar S, Mallegol I, Wu J, Moskovitz BL. Itraconazole oral solution versus clotrimazole troches for the treatment of oropharyngeal candidiasis in immunocompromised patients. Clin Ther 1997;19:471-80.
18. Wilcox CM, Darouiche RO, Laine L, Moskovitz BL, Mallegol I, Wu J. A randomized, double-blind comparison of itraconazole oral solution and fluconazole tablets in the treatment of esophageal candidiasis. J Infect Dis 1997;176:227-32.
19. Fessel WJ, Merrill KW, Ward DJ, et al. Itraconazole oral solution (IS) for the treatment of fluconazole-refractory oropharyngeal candidiasis (OC) in HIV-positive patients [abstr]. In: Program and abstracts of the 4th conference on retroviruses and opportunistic infections. Alexandria, VA: The Infectious Diseases Society of America, 1997:124.
20. Phillips P, Zemcov J, Mahmood W, Montaner JSG, Craib K, Clarke AM. Itraconazole cyclodextrin solution for fluconazole-refractory oropharyngeal candidiasis in AIDS: correlation of clinical response with in vitro susceptibility. AIDS 1996; 10:1369-76.
21. Prentice AG, Warnock DW, Johnson SAN, Phillips MJ, Oliver DA. Multiple dose pharmacokinetics of an oral solution of itraconazole in autologous bone marrow transplant recipients. J Antimicrob Chemother 1994;34:247-52.
22. Prentice AG, Warnock DW, Johnson SAN, Taylor PC, Oliver DA. Multiple dose pharmacokinetics of an oral solution of itraconazole in patients receiving chemotherapy for acute myeloid leukaemia. J Antimicrob Chemother 1995;36:657-63.